These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25714499)

  • 1. Pertussis models to inform vaccine policy.
    Campbell PT; McCaw JM; McVernon J
    Hum Vaccin Immunother; 2015; 11(3):669-78. PubMed ID: 25714499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.
    Luz PM; Codeço CT; Werneck GL; Struchiner CJ
    Epidemiol Infect; 2006 Aug; 134(4):850-62. PubMed ID: 16316489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of vaccination on the infectious diseases epidemiology: example of pertussis].
    Guiso N
    Med Sci (Paris); 2007 Apr; 23(4):399-403. PubMed ID: 17433230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of pertussis in industrialized countries].
    Baron S; Bégué P; Grimprel E
    Sante; 1994; 4(3):195-200. PubMed ID: 7921686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
    Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
    Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
    Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.
    de Greeff SC; de Melker HE; Westerhof A; Schellekens JF; Mooi FR; van Boven M
    Epidemiology; 2012 Nov; 23(6):852-60. PubMed ID: 23018969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination.
    Orenstein WA
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S147-50. PubMed ID: 10447034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The decline and resurgence of pertussis in the US.
    Rohani P; Drake JM
    Epidemics; 2011 Sep; 3(3-4):183-8. PubMed ID: 22094341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Global pertussis epidemiology and immunization strategies].
    Zhang WH
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):467-72. PubMed ID: 20084979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology.
    Pesco P; Bergero P; Fabricius G; Hozbor D
    Epidemics; 2014 Jun; 7():13-21. PubMed ID: 24928665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults.
    Nitsch-Osuch A; Korzeniewski K; Kuchar E; Zielonka T; Życińska K; Wardyn K
    Respir Physiol Neurobiol; 2013 Jun; 187(1):99-103. PubMed ID: 23419520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around...
    Rozenbaum MH; De Cao E; Westra TA; Postma MJ
    Expert Rev Vaccines; 2012 Dec; 11(12):1415-28. PubMed ID: 23252386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?
    Godfroid F; Denoël P; Poolman J
    Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.